{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:19:12Z","timestamp":1794745152106,"version":"4.9.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001732","name":"Danmarks Grundforskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.biopha.2026.119949","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:50:41Z","timestamp":1790110241000},"page":"119949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Circulating and matrix-associated type XI collagen epitopes as complementary biomarkers to support stromal-targeting concepts in solid tumors"],"prefix":"10.1016","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4979-621X","authenticated-orcid":false,"given":"Annika","family":"Hettich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Crespo","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars N.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2891-0762","authenticated-orcid":false,"given":"Inna M.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia S.","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susann","family":"Theile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie","family":"Bager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Willumsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2026.119949_bib1","article-title":"Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung","year":"2026","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"10.1016\/j.biopha.2026.119949_bib2","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1158\/1541-7786.MCR-23-0411","article-title":"Updating the definition of cancer","volume":"21","author":"Brown","year":"2023","journal-title":"Mol. Cancer Res."},{"issue":"12","key":"10.1016\/j.biopha.2026.119949_bib3","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.15252\/embr.201439246","article-title":"The extracellular matrix modulates the hallmarks of cancer","volume":"15","author":"Pickup","year":"2014","journal-title":"EMBO Rep."},{"issue":"5957","key":"10.1016\/j.biopha.2026.119949_bib4","first-page":"1216","article-title":"The extracellular matrix: not just pretty fibrils","volume":"326","author":"Hynes","year":"2009","journal-title":"Science (1979)"},{"issue":"12","key":"10.1016\/j.biopha.2026.119949_bib5","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005058","article-title":"Extracellular matrix degradation and remodeling in development and disease","volume":"3","author":"Lu","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119949_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s43556-026-00436-1","article-title":"The extracellular matrix: structure, composition, biological functions, diseases, and therapeutic targets","volume":"7","author":"Kamal","year":"2026","journal-title":"Mol. Biomed."},{"issue":"3","key":"10.1016\/j.biopha.2026.119949_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/bcr287","article-title":"The complexities of breast cancer desmoplasia","volume":"3","author":"Walker","year":"2001","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119949_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46340-4","article-title":"Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotype","volume":"13","author":"Wolf","year":"2023","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.biopha.2026.119949_bib9","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.cgh.2009.07.039","article-title":"Desmoplasia of pancreatic ductal adenocarcinoma","volume":"7","author":"Pandol","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119949_bib10","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1172\/JCI45817","article-title":"Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors","volume":"122","author":"Salmon","year":"2012","journal-title":"J. Clin. Investig."},{"issue":"23","key":"10.1016\/j.biopha.2026.119949_bib11","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2421061122","article-title":"Sequential drug release system: Targeting the tumor ECM for enhanced chemotherapy efficacy","volume":"122","author":"Cao","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2026.119949_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-026-03152-x","article-title":"Single-cell spatial pharmacobiology identifies conserved stromal barriers to therapeutic antibody delivery in human solid tumors","author":"Lu","year":"2026","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119949_bib13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ccr.2012.01.007","article-title":"Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma","volume":"21","author":"Provenzano","year":"2012","journal-title":"Cancer Cell."},{"issue":"1","key":"10.1016\/j.biopha.2026.119949_bib14","doi-asserted-by":"crossref","first-page":"S1130","DOI":"10.1016\/j.jtho.2016.11.1585","article-title":"P3.01-019 desmoplasia is associated with poor prognosis and carcinoma-associated fibroblast heterogeneity in non-small cell lung cancer","volume":"12","author":"Navab","year":"2017","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119949_bib15","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004978","article-title":"The collagen family","volume":"3","author":"Ricard-Blum","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.biopha.2026.119949_bib16","series-title":"Biochemistry of Collagens, Laminins and Elastin","author":"Karsdal","year":"2023"},{"key":"10.1016\/j.biopha.2026.119949_bib17","unstructured":"U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Letter of Support for PRO-C3 as a Proposed Prognostic Biomarker of Risk of Survival Outcomes in Clinical Trials of Patients with Solid Tumors. 2023. Accessed July 24, 2026. https:\/\/www.fda.gov\/media\/169332\/download."},{"key":"10.1016\/j.biopha.2026.119949_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.117420","article-title":"Plasma levels of PRO-C3, a type III collagen synthesis marker, are associated with arterial stiffness and increased risk of cardiovascular death","volume":"388","author":"Genovese","year":"2024","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.biopha.2026.119949_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/00365521.2017.1392596","article-title":"PRO-C3: a new and more precise collagen marker for liver fibrosis in patients with chronic hepatitis C","volume":"53","author":"Hansen","year":"2018","journal-title":"Scand. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119949_bib20","article-title":"PRO-C3 is a predictor of clinical outcomes in distinct cohorts of patients with advanced liver disease","volume":"5","author":"Nielsen","year":"2023","journal-title":"JHEP Rep."},{"issue":"23","key":"10.1016\/j.biopha.2026.119949_bib21","doi-asserted-by":"crossref","first-page":"11345","DOI":"10.1016\/S0021-9258(18)60965-2","article-title":"Type XI collagen is a heterotrimer with the composition (1 alpha, 2 alpha, 3 alpha) retaining non-triple-helical domains","volume":"262","author":"Morris","year":"1987","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.biopha.2026.119949_bib22","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.1074\/jbc.275.14.10370","article-title":"Collagen XI nucleates self-assembly and limits lateral growth of cartilage fibrils","volume":"275","author":"Blaschke","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"June","key":"10.1016\/j.biopha.2026.119949_bib23","first-page":"1","article-title":"Collagen XI Alpha 1 chain, a novel therapeutic target for cancer treatment","volume":"12","author":"Wu","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119949_bib24","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100054RR","article-title":"Collagen XI alpha 1 chain, a potential therapeutic target for cancer","volume":"35","author":"Liu","year":"2021","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.biopha.2026.119949_bib25","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3390\/cancers13050935","article-title":"Collagen type XI alpha 1 (COL11A1): a novel biomarker and a key player in cancer","volume":"13","author":"Nallanthighal","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.biopha.2026.119949_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.canlet.2016.09.001","article-title":"A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets","volume":"382","author":"Jia","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119949_bib27","article-title":"Overexpression of COL11A1 by cancer-associated fibroblasts: clinical relevance of a stromal marker in pancreatic cancer","volume":"8","author":"Garc\u00eda-Pravia","year":"2013"},{"key":"10.1016\/j.biopha.2026.119949_bib28","article-title":"The Dynamic Changes of COL11A1 Expression During the Carcinogenesis and Development of Breast Cancer and as a Candidate Diagnostic and Prognostic Marker","volume":"2025","author":"Wang","year":"2025"},{"issue":"11","key":"10.1016\/j.biopha.2026.119949_bib29","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.3390\/cancers12113108","article-title":"Cancer-associated fibroblasts: understanding their heterogeneity","volume":"12","author":"Louault","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.biopha.2026.119949_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/path.6207","article-title":"The collagen landscape in cancer: profiling collagens in tumors and in circulation reveals novel markers of cancer-associated fibroblast subtypes","volume":"262","author":"Thorlacius-Ussing","year":"2024","journal-title":"J. Pathol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119949_bib31","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1038\/bjc.2013.624","article-title":"Collagen type XI \u03b11 facilitates head and neck squamous cell cancer growth and invasion","volume":"109","author":"Sok","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2026.119949_bib32","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/carcin\/22.6.875","article-title":"Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2","volume":"22","author":"Fischer","year":"2001","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.biopha.2026.119949_bib33","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.canlet.2014.12.011","article-title":"Tumor matrix protein collagen XI\u03b11 in cancer","volume":"357","author":"Raglow","year":"2015","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.biopha.2026.119949_bib34","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/s41379-019-0286-9","article-title":"Collagen (XI) alpha-1 chain is an independent prognostic factor in breast ductal carcinoma in situ","volume":"32","author":"Toss","year":"2019","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119949_bib35","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ijc.33551","article-title":"Noninvasive prognostic biomarker potential of quantifying the propeptides of Type XIcollagen alpha-1 chain (PRO-C11) in patients with pancreatic ductal adenocarcinoma","volume":"149","author":"Nissen","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119949_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12920-024-01863-1","article-title":"Analysis of cancer-associated fibroblasts related genes identifies COL11A1 associated with lung adenocarcinoma prognosis","volume":"17","author":"Zheng","year":"2024","journal-title":"BMC Med. Genom."},{"issue":"3","key":"10.1016\/j.biopha.2026.119949_bib37","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2026.119949_bib38","article-title":"Single-cell analysis reveals the COL11A1+ fibroblasts are cancer-specific fibroblasts that promote tumor progression","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119949_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97538-3","article-title":"Irinotecan and its metabolite SN38 inhibits procollagen I production of dermal fibroblasts from Systemic Sclerosis patients","volume":"11","author":"Lapoirie","year":"2021","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2026.119949_bib40","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1476-5381.2009.00387.x","article-title":"The Scar-in-a-Jar: studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well","volume":"158","author":"Chen","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119949_bib41","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3390\/cancers14030819","article-title":"Collagen Biomarkers Quantify Fibroblast Activity In Vitro and Predict Survival in Patients with Pancreatic Ductal Adenocarcinoma","volume":"14","author":"Nissen","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"15","key":"10.1016\/j.biopha.2026.119949_bib42","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.clinbiochem.2010.07.025","article-title":"Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP) \u2014 Assessment of corresponding epitopes","volume":"43","author":"Leeming","year":"2010","journal-title":"Clin. Biochem."},{"issue":"27","key":"10.1016\/j.biopha.2026.119949_bib43","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1200\/JCO.21.02511","article-title":"Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC)","volume":"40","author":"Chen","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119949_bib44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbapap.2011.10.002","article-title":"Cysteine cathepsins: From structure, function and regulation to new frontiers","volume":"1824","author":"Turk","year":"2012","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Proteins Proteom."},{"issue":"1","key":"10.1016\/j.biopha.2026.119949_bib45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12876-025-03645-0","article-title":"Collagen turnover biomarkers to predict outcome of patients with biliary cancer","volume":"25","author":"Kaps","year":"2025","journal-title":"BMC Gastroenterol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119949_bib46","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/ijc.34356","article-title":"Blood-based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer","volume":"152","author":"Christensen","year":"2023","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2026.119949_bib47","doi-asserted-by":"crossref","DOI":"10.1177\/18758592261468629","article-title":"Collagen turnover biomarkers as diagnostic, prognostic, and therapy monitoring indicators in gastric cancer","volume":"43","author":"Kaps","year":"2026","journal-title":"Cancer Biomark."},{"issue":"9","key":"10.1016\/j.biopha.2026.119949_bib48","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1021\/bc200158j","article-title":"Cancer-Stroma Targeting Therapy by Cytotoxic Immunoconjugate Bound to the Collagen 4 Network in the Tumor Tissue","volume":"22","author":"Yasunaga","year":"2011","journal-title":"Bioconjug Chem."},{"issue":"9","key":"10.1016\/j.biopha.2026.119949_bib49","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1158\/1535-7163.MCT-22-0099","article-title":"Anti-Extra Domain B Splice Variant of Fibronectin Antibody\u2013Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade","volume":"21","author":"Hooper","year":"2022","journal-title":"Mol. Cancer Ther."},{"issue":"8","key":"10.1016\/j.biopha.2026.119949_bib50","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrc1893","article-title":"Drug penetration in solid tumours","volume":"6","author":"Minchinton","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2026.119949_bib51","doi-asserted-by":"crossref","unstructured":"Yamazaki C.M., Yamaguchi A., Anami Y., et al. Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance. Preprint posted online December 21, 2020. doi:10.1101\/2020.12.18.423326.","DOI":"10.1101\/2020.12.18.423326"},{"issue":"1","key":"10.1016\/j.biopha.2026.119949_bib52","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13046-020-01797-3","article-title":"Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study","volume":"39","author":"Bon","year":"2020","journal-title":"J. Exp. & Clin. Cancer Res."},{"issue":"26","key":"10.1016\/j.biopha.2026.119949_bib53","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1038\/onc.2013.307","article-title":"COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer","volume":"33","author":"Wu","year":"2014","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.biopha.2026.119949_bib54","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.prp.2016.03.005","article-title":"Overexpression of \u03b11 chain of type XI collagen (COL11A1) aids in the diagnosis of invasive carcinoma in endoscopically removed malignant colorectal polyps","volume":"212","author":"Zhang","year":"2016","journal-title":"Pathol. Res. Pract."},{"issue":"6","key":"10.1016\/j.biopha.2026.119949_bib55","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1086\/522377","article-title":"A functional polymorphism in COL11A1, which encodes the \u03b11 chain of type XI collagen, is associated with susceptibility to lumbar disc herniation","volume":"81","author":"Mio","year":"2007","journal-title":"Am. J. Human. Genet."},{"key":"10.1016\/j.biopha.2026.119949_bib56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.matbio.2020.09.001","article-title":"Collagen XI regulates the acquisition of collagen fibril structure, organization and functional properties in tendon","volume":"94","author":"Sun","year":"2020","journal-title":"Matrix Biol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119949_bib57","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nrc1949","article-title":"multifunctional enzymes in cancer","volume":"6","author":"Mohamed","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"23","key":"10.1016\/j.biopha.2026.119949_bib58","first-page":"6027","article-title":"Cathepsin B expression and localization in glioma progression and invasion","volume":"54","author":"Rempel","year":"1994","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2026.119949_bib59","first-page":"301","article-title":"Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival","volume":"145","author":"Campo","year":"1994","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119949_bib60","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1208\/s12248-022-00720-2","article-title":"Selection of Payloads for Antibody\u2013Drug Conjugates Targeting Ubiquitously Expressed Tumor-Associated Antigens: a Case Study","volume":"24","author":"Yao","year":"2022","journal-title":"AAPS J."},{"issue":"16","key":"10.1016\/j.biopha.2026.119949_bib61","first-page":"4187","article-title":"Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11","volume":"51","author":"Kawato","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119949_bib62","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2147\/IJN.S435407","article-title":"Research Progress of SN38 Drug Delivery System in Cancer Treatment","volume":"19","author":"Qi","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.biopha.2026.119949_bib63","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/15384101.2016.1253641","article-title":"Cell proliferation downregulated by TGF-\u03b22-triggered G1\/S checkpoint in clinical CAFs","volume":"16","author":"Wu","year":"2017","journal-title":"Cell. Cycle"},{"issue":"5A","key":"10.1016\/j.biopha.2026.119949_bib64","first-page":"3499","article-title":"Topoisomerase-I inhibitor SN-38 can induce DNA damage and chromosomal aberrations independent from DNA synthesis","volume":"18","author":"Voigt","year":"1998","journal-title":"Anticancer. Res."},{"issue":"15","key":"10.1016\/j.biopha.2026.119949_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500262","article-title":"Linker Design for the Antibody Drug Conjugates: A Comprehensive Review","volume":"20","author":"Lei","year":"2025","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.biopha.2026.119949_bib66","first-page":"38","article-title":"Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma","volume":"51","author":"Kruszewski","year":"2004","journal-title":"Neoplasma"},{"issue":"6","key":"10.1016\/j.biopha.2026.119949_bib67","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/pmic.200401030","article-title":"Overexpression of cathepsin B in gastric cancer identified by proteome analysis","volume":"5","author":"Ebert","year":"2005","journal-title":"Proteomics"},{"issue":"1","key":"10.1016\/j.biopha.2026.119949_bib68","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-016-0503-9","article-title":"Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients","volume":"15","author":"Ruan","year":"2016","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2026.119949_bib69","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/antib15020021","article-title":"Two highly specific mouse monoclonal antibodies to the putative C-telopeptide of human collagen XI\u03b11, a cancer biomarker","volume":"15","author":"Garc\u00eda-Oca\u00f1a","year":"2026","journal-title":"Antibodies"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:51:33Z","timestamp":1794743493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226009856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":69,"alternative-id":["S0753332226009856"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119949","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating and matrix-associated type XI collagen epitopes as complementary biomarkers to support stromal-targeting concepts in solid tumors","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119949"}}